We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The OptiScanner 5000, which already has a CE mark, may now be used in surgical intensive care units (SICUs) to monitor plasma glucose levels and dysglycemia in patients, the company said in a statement.